Patient Square Capital LP
Source: SEC Form 13F · as of Mar 2026Patient Square Capital LP holds 18 biotech & pharma companies tracked by BioSniper, totaling $425.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$425.3M
BioSniper AIPage context preserved
Prepared research question
What matters most for Roivant Sciences Ltd. (ROIV)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ROIVRoivant Sciences Ltd. | 8,166,047 | $226.2M |
| ARGXARGENX SE | 36,718 | $26.8M |
| INSMINSMED Inc | 157,500 | $25.8M |
| ONCBeOne Medicines Ltd. | 80,542 | $23.9M |
| COGTCogent Biosciences, Inc. | 596,000 | $22.9M |
| NKTRNEKTAR THERAPEUTICS | 210,000 | $15.1M |
| PHVSPharvaris N.V. | 493,000 | $13.9M |
| ABVXAbivax SA | 121,245 | $13.5M |
| ARQTArcutis Biotherapeutics, Inc. | 400,645 | $9.4M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 93,882 | $7.9M |
| ELVNEnliven Therapeutics, Inc. | 200,000 | $7.8M |
| CATXPerspective Therapeutics, Inc. | 1,625,000 | $6.8M |
| DFTXDefinium Therapeutics Inc. | 331,000 | $6.3M |
| HROWHARROW, INC. | 165,209 | $5.8M |
| CTMXCytomX Therapeutics, Inc. | 1,085,790 | $5.1M |
| RCUSArcus Biosciences, Inc. | 195,000 | $4.2M |
| ASMBASSEMBLY BIOSCIENCES, INC. | 136,315 | $3.8M |
| SYRESpyre Therapeutics, Inc. | 1,000 | $50K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.